<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03980132</url>
  </required_header>
  <id_info>
    <org_study_id>LIGRADIS</org_study_id>
    <nct_id>NCT03980132</nct_id>
  </id_info>
  <brief_title>Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease.</brief_title>
  <acronym>LIGRADIS</acronym>
  <official_title>Randomized Clinical Trial, Blinded for the Researcher and Multicenter, to Evaluate the Efficacy and Safety of Preoperative Preparation With Lugol Solution in Euthyroid Patients With Graves-Basedow Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jesús María Villar del Moral</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Currently, both the American Thyroid Association and the European Thyroid Association&#xD;
      recommend the use of Lugol Solution (LS) in the preparation of patients undergoing&#xD;
      thyroidectomy for Graves' disease (GD), but their recommendations are based on a low level of&#xD;
      evidence. This means that its use is not generalized among the different endocrine surgery&#xD;
      units.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      Study population: 270 patients (135 patients in each arms) undergoing total thyroidectomy&#xD;
      (TT) due to GD in Spanish hospitals, which perform a minimum of 100 thyroidectomies a year,&#xD;
      at least 10 of them for GD.&#xD;
&#xD;
      Variables:&#xD;
&#xD;
      Preoperative variables&#xD;
&#xD;
        -  Demographic variables: birthdate, gender and ethnicity.&#xD;
&#xD;
        -  Drugs allergies. Allergy to iodine.&#xD;
&#xD;
        -  Personal history and usual treatment.&#xD;
&#xD;
        -  Aspects related to the GD: date of diagnosis, use of AT drugs and/or radioiodine,&#xD;
           existence of ophthalmopathy, existence of cervical compression symptoms and indication&#xD;
           of surgery.&#xD;
&#xD;
        -  Physical exploration: body mass index, pulse at rest and blood pressure and cervical&#xD;
           palpation.&#xD;
&#xD;
        -  Laboratory tests: hematocrit, leukocytes, neutrophils, platelets, international&#xD;
           normalized ratio(INR), creatinine, potassium, total calcium, albumin, total proteins,&#xD;
           parathormone (PTH), 25-hydroxide-vitamin D, free T4 and / or free T3, TSH, thyroid&#xD;
           stimulating immunoglobulin (TSI).&#xD;
&#xD;
        -  Classification of the anesthetic risk of ASA.&#xD;
&#xD;
        -  Cervical ultrasound: existence of thyroid nodules and volume of the thyroid.&#xD;
&#xD;
        -  Mobility of the vocal cords evaluated by laryngoscopy.&#xD;
&#xD;
        -  Compliance with assigned treatment: the patient assigned to the LS arm must have&#xD;
           consumed at least 80% of the total dose indicated.&#xD;
&#xD;
      Intraoperative variables&#xD;
&#xD;
        -  Surgical time.&#xD;
&#xD;
        -  Antibiotic prophylaxis&#xD;
&#xD;
        -  Intraoperative hemorrhage.&#xD;
&#xD;
        -  Thyroidectomy Difficulty Scale.&#xD;
&#xD;
        -  Loss of electromyographic signal during neural intraoperative monitorization.&#xD;
&#xD;
        -  Accidental parathyroidectomy.&#xD;
&#xD;
        -  Section or obvious lesion of the recurrent laryngeal nerve.&#xD;
&#xD;
        -  Trachea or esophagus perforation.&#xD;
&#xD;
        -  Weight of the gland.&#xD;
&#xD;
        -  Electrosurgical hemostasis system used during the intervention.&#xD;
&#xD;
        -  Maneuvers used to check hemostasis.&#xD;
&#xD;
        -  Hemostats used during the intervention.&#xD;
&#xD;
        -  Use of drainage.&#xD;
&#xD;
        -  Definitive surgical technique: TT, unilateral or bilateral subtotal thyroidectomy or&#xD;
           hemithyroidectomy.&#xD;
&#xD;
      Postoperative variables&#xD;
&#xD;
        -  Early complications: hypoparathyroidism, paralysis of the recurrent laryngeal nerve,&#xD;
           postoperative hematoma, surgical site infection or death.&#xD;
&#xD;
        -  Debit for surgical drains.&#xD;
&#xD;
        -  Postoperative hospital long of stay.&#xD;
&#xD;
        -  Anatomopathological variables: histological diagnosis compatible with GD and existence&#xD;
           of parathyroid glands in the surgical specimen.&#xD;
&#xD;
        -  Long-term complications: hypocalcemia and/or permanent vocal cord paralysis longer than&#xD;
           6 months&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 25, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">January 31, 2023</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>To analyze whether, in euthyroid patients undergoing TT due to GD, preoperative non-preparation with LS increases the appearance of postoperative complications compared to the use of LS preparation. The main variable will be the rate of postoperative complication: hypoparathyroidism, recurrent laryngeal nerve injury, hematoma, surgical site infection or death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Surgical difficulty</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Score of the difficulty of the surgery by the surgeon through the Thyroidectomy Difficulty Scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative hemorrhage</measure>
    <time_frame>Intraoperatively</time_frame>
    <description>Amount of blood lost during the thyroidectomy in dL.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical time.</measure>
    <time_frame>Intraoperatively.</time_frame>
    <description>Time from surgical incision to skin closure in minutes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative neuromonitoring.</measure>
    <time_frame>Intraoperatively.</time_frame>
    <description>Rate of patients with loss of electromyographic signal during intraoperative neuromonitoring.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Long of Stay</measure>
    <time_frame>30 days after surgery</time_frame>
    <description>Days to hospital discharge after surgery.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmissions</measure>
    <time_frame>30 days after surgery.</time_frame>
    <description>Rate of readmissions.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Permanent complications</measure>
    <time_frame>180 days after surgery</time_frame>
    <description>Rate of patients with permanent complications, including hypoparathyroidism or recurrent laryngeal nerve injury.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>180 days after surgery</time_frame>
    <description>Number of patients with an adverse event after administration of Lugol solution.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">270</enrollment>
  <condition>Hyperthyroidism, Autoimmune</condition>
  <arm_group>
    <arm_group_label>Preoperative Lugol Solution preparation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive Lugol Solution preparation for 10 days before thyroidectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No preparation</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will not receive preparation before thyroidectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lugols Strong Iodine</intervention_name>
    <description>5 L.I. drops / 8 hours for 10 days before surgery</description>
    <arm_group_label>Preoperative Lugol Solution preparation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients who meet all of the following criteria will be eligible:&#xD;
&#xD;
          -  The age of the patient must be over 18 years of age.&#xD;
&#xD;
          -  The patient or his / her tutor, in cases where this is the case, has the capacity to&#xD;
             understand the study and agrees to participate in it, by signing the corresponding&#xD;
             informed consent document.&#xD;
&#xD;
          -  Patients who have been diagnosed with GD, defined as the existence of hyperthyroidism&#xD;
             (TSH &lt; lower limit of laboratory normality associated with TSI &gt; upper limit of&#xD;
             laboratory normality) that present ultrasonographic data (diffuse vascularization&#xD;
             increase) and / or scintigraphy (diffuse uptake of the radioisotope) compatible with&#xD;
             GD.&#xD;
&#xD;
          -  Euthyroid patients (free T4 and / or free T3 within the normal range of the&#xD;
             laboratory) at the time of randomization, and under treatment with AT drugs&#xD;
             (propylthiouracil, carbimazole or methimazole).&#xD;
&#xD;
          -  The patient must be proposed for total thyroidectomy, using a transcervical approach.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        The participant can not participate in the study if he / she presents any of the following&#xD;
        circumstances:&#xD;
&#xD;
          -  Prior cervicotomy by surgical intervention on the thyroid or parathyroid gland.&#xD;
&#xD;
          -  Associated hyperparathyroidism that requires associating a parathyroidectomy in the&#xD;
             same surgical act.&#xD;
&#xD;
          -  Associated thyroid cancer that requires adding a lymph node dissection of the central&#xD;
             or lateral compartment in the same surgical time.&#xD;
&#xD;
          -  Iodine allergy.&#xD;
&#xD;
          -  Consumption of lithium or amiodarone between randomization and administration of LS.&#xD;
&#xD;
          -  Patients with category IV of the anesthetic risk classification of the American&#xD;
             Society of Anesthesiologists (ASA).&#xD;
&#xD;
          -  Women who breastfeed during the administration of the LS or in the month after it.&#xD;
&#xD;
          -  Preoperative palsy of a vocal cord verified by laryngoscopy.&#xD;
&#xD;
          -  Surgery performed by training specialists, or by staff not specifically dedicated to&#xD;
             endocrine surgery.&#xD;
&#xD;
          -  Surgery not performed under general anesthesia.&#xD;
&#xD;
          -  Endoscopic surgery, video assisted or by remote approach.&#xD;
&#xD;
          -  Surgery performed in out-patient settings.&#xD;
&#xD;
          -  Current drug consumption or alcohol abuse that could interfere with meeting the study&#xD;
             requirements.&#xD;
&#xD;
          -  Participation in any other trial with medications in the month prior to randomization.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jesús María Villar del Moral</last_name>
    <phone>+34958020349</phone>
    <email>jesusm.villar.sspa@juntadeandalucia.es</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>José Luis Muñoz de Nova</last_name>
    <phone>+34915202448</phone>
    <email>jmunoz@salud.madrid.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Universitario de Bellvitge</name>
      <address>
        <city>Hospitalet de Llobregat</city>
        <state>Barcelona</state>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pablo Moreno Llorente</last_name>
      <phone>+34932607621</phone>
      <email>pmoreno@bellvitgehospital.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Donostia</name>
      <address>
        <city>San Sebastián</city>
        <state>Guipúzcoa</state>
        <zip>20014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lander Gallego Otaegui</last_name>
      <phone>+34943007000</phone>
      <email>lander.gallegootaegui@osakidetza.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario</name>
      <address>
        <city>Santiago De Compostela</city>
        <state>La Coruña</state>
        <zip>15706</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elena Gamborino Caramés</last_name>
      <phone>+34981951432</phone>
      <email>elena.gamborino.carames@sergas.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Insular de Gran Canaria</name>
      <address>
        <city>Las Palmas De Gran Canaria</city>
        <state>Las Palmas</state>
        <zip>35016</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>María Isabel Gutiérrez Giner</last_name>
      <phone>+34928441652</phone>
      <email>mgutgin@gobiernodecanarias.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Puerta de Hierro</name>
      <address>
        <city>Majadahonda</city>
        <state>Madrid</state>
        <zip>28222</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mariano Artés Caselles</last_name>
      <phone>+34911916184</phone>
      <email>mariano.artes@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Virgen de la Arrixaca</name>
      <address>
        <city>El Palmar</city>
        <state>Murcia</state>
        <zip>30120</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>José Manuel Rodríguez González</last_name>
      <phone>+34968369500</phone>
      <email>jmrodri@um.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Cruces</name>
      <address>
        <city>Baracaldo</city>
        <state>Vizcaya</state>
        <zip>48903</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aitor de la Quintana Basarrate</last_name>
      <phone>+34946006068</phone>
      <email>aitor.quintanadelabasarrate@osakidetza.eus</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de Basurto</name>
      <address>
        <city>Bilbao</city>
        <state>Vizcaya</state>
        <zip>48013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maitane García Carrillo</last_name>
      <phone>+34944006000</phone>
      <email>maitane.garciacarrillo@osakidetza.eus</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario del Mar</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leyre Lorente Poch</last_name>
      <phone>+34932483000</phone>
      <email>lorentepoch@live.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Óscar Vidal Pérez</last_name>
      <phone>+34932275718</phone>
      <email>ovidal@clinic.cat</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de las Nieves</name>
      <address>
        <city>Granada</city>
        <zip>18014</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesús María Villar del Moral</last_name>
      <phone>+34958020349</phone>
      <email>jesusm.villar.sspa@juntadeandalucia.es</email>
    </contact>
    <contact_backup>
      <last_name>Nuria Muñoz Pérez</last_name>
      <phone>+34958020349</phone>
      <email>numupe@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario de La princesa</name>
      <address>
        <city>Madrid</city>
        <zip>28006</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Luis Muñoz de Nova, MD</last_name>
      <phone>+34915202447</phone>
      <email>jmunoz@salud.madrid.org</email>
    </contact>
    <investigator>
      <last_name>José Luis Muñoz de Nova, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital General Universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enrique Mercader Cidoncha</last_name>
      <phone>+34915868348</phone>
      <email>enrique.mercader@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Ramón y Cajal</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquín Gómez Ramírez</last_name>
      <phone>+34913368000</phone>
      <email>joaquin.gomez@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Fundación Jiménez Díaz</name>
      <address>
        <city>Madrid</city>
        <zip>28040</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Osorio Silla</last_name>
      <phone>+34915504800</phone>
      <email>irene.osorio@quironsalud.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario 12 de Octubre</name>
      <address>
        <city>Madrid</city>
        <zip>28041</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Javier Guadarrama González</last_name>
      <phone>+34913908000</phone>
      <email>fjavier.guadarrama@salud.madrid.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complejo Asistencial Universitario de Salamanca</name>
      <address>
        <city>Salamanca</city>
        <zip>37007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guzmán Franch Arcas</last_name>
      <phone>+34923291100</phone>
      <email>gfranch@saludcastillayleon.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen Macarena</name>
      <address>
        <city>Sevilla</city>
        <zip>41009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Consuelo Marín Velarde</last_name>
      <phone>+34955008000</phone>
      <email>consuelomarinvelarde@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen del Rocío</name>
      <address>
        <city>Sevilla</city>
        <zip>41013</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Manuel Martos Martínez</last_name>
      <phone>+34955012313</phone>
      <email>juan.martos.sspa@juntadeandalucia.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario</name>
      <address>
        <city>Valencia</city>
        <zip>16010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joaquín Ortega Serrano</last_name>
      <phone>+34961973833</phone>
      <email>joaquin.ortega@uv.es</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hospital Clínico Universitario Lozano Blesa</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susana Ros López</last_name>
      <phone>+34976768884</phone>
      <email>susanaros44@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Muñoz de Nova JL, Franch-Arcas G, Mejía-Abril GP, Flores-Ruiz ME, Muñoz-Pérez N, Pintos-Sánchez E, Guadarrama González FJ, Valdés de Anca Á, Mercader-Cidoncha E, de la Quintana-Basarrate A, Osorio-Silla I, Ros-López S, Gallego-Otaegui L, Santos-Molina E, Martínez-Nieto C, Gamborino-Caramés E, Artés-Caselles M, Lorente-Poch L, García-Carrillo M, Moreno-Llorente P, Marín-Velarde C, Ortega-Serrano J, Martos-Martínez JM, Vidal-Pérez O, Luengo-Pierrard P, Villar-Del-Moral JM. Efficacy and safety of preoperative preparation with Lugol's iodine solution in euthyroid patients with Graves' disease (LIGRADIS Trial): Study protocol for a multicenter randomized trial. Contemp Clin Trials Commun. 2021 Jun 15;22:100806. doi: 10.1016/j.conctc.2021.100806. eCollection 2021 Jun.</citation>
    <PMID>34195471</PMID>
  </results_reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 30, 2019</study_first_submitted>
  <study_first_submitted_qc>June 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2019</study_first_posted>
  <last_update_submitted>July 4, 2021</last_update_submitted>
  <last_update_submitted_qc>July 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Fundación de Investigación Biomédica - Hospital Universitario de La Princesa</investigator_affiliation>
    <investigator_full_name>Jesús María Villar del Moral</investigator_full_name>
    <investigator_title>Head of General and Digestive Surgery - H. U. Virgen de las Nieves</investigator_title>
  </responsible_party>
  <keyword>Thyroid Surgery</keyword>
  <keyword>Grave' Disease</keyword>
  <keyword>Lugol Solution</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Graves Disease</mesh_term>
    <mesh_term>Hyperthyroidism</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

